tirzepatide research chemical | CAS#2023788-19-2 | GIP/GLP-1 Receptor Agonist Tirzepatide - Metabolic / GLP

Prescription Care If appropriate, your clinician might prescribe FDA-approved medications like tirzepatide or other GLP-1s

[1] Wegovy follows a more gradual escalation schedule over 1620 weeks: Weeks 14 : 0.25 mg once weekly Weeks 58 : 0.5 mg once weekly Weeks 912 : 1 mg once weekly Weeks 1316 : 1.7 mg once weekly Week 17 onward : 2.4 mg once weekly (maintenance dose) If patients do not tolerate a dose during titration, the prescribing information allows for delaying dose escalation for additional weeks

Monthly and annual savings caps apply

M., da Silva, A

Pharmacy Price Comparison Prices for prescription medications can vary significantly between pharmacies sometimes by $100 or more